Caveolae and caveolins

Current Opinion in Cell Biology

Volumn 8, Issue 4, 1996, Pages 542-548

  Parton, Robert G ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CAVEOLIN; CHOLESTEROL; GUANINE NUCLEOTIDE BINDING PROTEIN;

BIOGENESIS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION;

EID: 0030222108     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-0674(96)80033-0     Document Type: Article

References (60)

1. 1. Palade GE: Fine structure of blood capillaries. J Appl Physics 1953, 24:1424.
2. 2. Schnitzer JE, Oh P, Pinney E, Allard J: Filipin-sensitive caveolae-mediated transport in endothelium: reduced transcytosis, scavenger endocytosis, and capillary permeability of select macromolecules. J Cell Biol 1994, 127:1217-1232.
3. 3. Andersen RGW: Potocytosis of small molecules and ions by caveolae. Trends Cell Biol 1993, 3:69-72.
4. 4. Lisanti MP, Scherer PE, Tang Z-L, Sargiacomo M: Caveolae, caveolin and caveolin-rich membrane domains: a signalling hypothesis. Trends Cell Biol 1994, 4:231-235.
5. 5. Glenney JR, Soppet D: Sequence and expression of caveolin, a protein component of caveolae plasma membrane domains phosphorylated on tyrosine in Rous sarcoma virus-transformed fibroblasts. Proc Natl Acad Sci USA 1992, 89:10517-10521.
6. 6. Kurzchalia TV, Dupree P, Parton RG, Kellner R, Virta H, Lehnert M, Simons K: VIP21, a 21 KD membrane protein is an integral component of trans-Golgi network-derived transport vesicles. J Cell Biol 1992, 118:1003-1014.
7. 7. Rothberg K, Heuser JE, Donzell WC, Ying Y-S, Glenney JR, Andersen RGW: Caveolin, a protein component of caveolae membrane coats. Cell 1992, 68:673-682.
8. 8. Scherer PE, Lisanti MP, Baldini G, Sargiacomo M, Mastick CC, Lodish HF: Induction of caveolin during adipogenesis and association of GLUT4 with caveolin-rich vesicles. J Cell Biol 1994, 127:1233-1243.
9. 9. Kandror KV, Stephens JM, Pilch PF: Expression and compartmentalization of caveolin in adipose cells: coordinate regulation with and structural segregation from GLUT4. J Cell Biol 1995, 129:999-1006. Caveolin expression increases during differentiation of fibroblasts into 3T3 adipocytes. In contrast to the results of a previous study [8], caveolin and the glucose transporter, GLUT4, are clearly shown, by using an immuno-isolation approach, to be in distinct vesicles.
10. 10. Koleske AJ, Baltimore D, Lisanti MP: Reduction of caveolin and caveolae in oncogenically transformed cells. Proc Natl Acad Sci USA 1995, 92:1381-1385. Oncogenic transformation leads to a reduction in the level of caveolin-1 in NIH-3T3 cells and to a loss of detectable caveolae. This intriguing result suggests that caveolae could play some role in the phenotypic changes (for example loss of contact inhibition) that accompany cell transformation.
11. 11. Dupree P, Parton RG, Raposo G, Kurzchatta TV, Simons K: Caveolae and sorting in the trans-Golgi-network of epithelial cells. EMBO J 1993, 12:1597-1605.
12. 12. Dietzen DJ, Hastings WR, Lublin DM: Caveolin is palmitoylated on multiple cysteine residues. Palmitoylation is not necessary for localization of caveolin to caveolae. J Biol Chem 1995, 270:6838-6842.
13. 13. Monier S, Parton RG, Vogel F, Henske A, Kurzchalia TV: VIP21-caveolin, a membrane protein constituent of the caveolar coat, forms high molecular mass oligomers in vivo and in vitro. Mol Biol Cell 1995, 6:911-927. This paper describes the translation, oligomerization and purification of VIP21-caveolin (caveolin-1). Caveolin-1 is synthesized and imported into microsomes cotranslationally and quickly oligomerizes in vitro. Both amino and carboxyl termini face the cytoplasm as originally proposed [11]. Oligomers formed in vivo are shown to be resistant to SDS and are analyzed by both biochemical and morphological methods. Mutational studies defined domains of the molecule required for oligomerization and for establishing the unusual hairpin topology of the molecule.
14. 14. Scherer PE, Tang Z, Chun M, Sargiacomo M, Lodish HF, Lisanti MP: Caveolin isoforms differ in their N-terminal protein sequence and subcellular distribution. Identification and epitope mapping of an isoform-specific monoclonal antibody probe. J Biol Chem 1995, 270:16395-16401.
15. 15. Way M, Parton RG: M-caveolin, a muscle-specific caveolin-related protein. FEBS Letts 1995, 376:108-112. Describes the molecular characterization of the first caveolin-related protein, thus defining a multigene family of caveolins. M-caveolin (renamed caveolin-3 as suggested in [16•]) is expressed preferentially in muscle cells and is induced upon muscle differentiation. Transient expression in fibroblasts causes M-caveolin to be targeted to caveolae.
16. 16. Tang Z, Scherer PE, Okamoto T, Song K, Chu C, Kohtz DS, Nishimolo I, Lodish HF, Lisanti MP: Molecular cloning of caveolin-3, a novel member of the caveolin gene family expressed predominantly in muscle. J Biol Chem 1996, 271:2255-2261. Describes the molecular characterization of caveolin-3 (M-caveolin; see [15•]). Caveolin-3 is present within detergent-insoluble complexes, forms oligomers and interacts with trimeric G proteins. The proposed GAP-like and GDI-like activities of caveolin-3 suggest an unusual interaction of caveolin-3 with both the GTP-bound and the GDP-bound forms of trimeric G protein α subunits.
17. 17. Scherer PE, Okamoto T, Chun M, Lodish HF, Lisanti MP: Identification, sequence, and expression of caveolin-2 defines a caveolin gene family. Proc Natl Acad Sci USA 1996, 93:131-135. Details the molecular and functional characterization of caveolin-2. Caveolin-2 shows a similar distribution to caveolin-1 but it displays a GAP-like, rather than a GDI-like, activity.
18. 18. Li S, Okamoto T, Chun M, Sargiacomo M, Casanova JE, Hansen SH, Nishimoto I, Lisanti MP: Evidence for a regulated interaction between heterotrimeric G proteins and caveolin. J Biol Chem 1995, 270:15693-15701. This paper provided the first evidence for a specific interaction between caveolin (specifically caveolin-1) and trimeric G protein subunits. A polypeptide containing amino acids 82-101 of caveolin-1 was shown to interact specifically with inactive G protein a subunits and to have GDI-like activity. These results led to a model of caveolin function in regulating G-protein activity.
19. 19. Neer EJ: Heterotrimeric G proteins: organizers of transmembrane signals. Cell 1995, 80:249-257.
20. 20. Chun M, Liyanage UK, Lisanti MP. Lodish HF: Signal transduction of a G protein-coupled receptor in caveolae: colocalization of endothelin and its receptor with caveolin. Proc Natl Acad Sci USA 1994, 91:11728-11732.
21. 21. Fujimoto T: Calcium pump of the plasma membrane is localized in caveolae. J Cell Biol 1993, 120:1147-1157.
22. 22. Fujimoto T, Nakade S, Miyawaki A, Mikoshiba K, Ogawa K: Localization of inositol 1,4,5,-triphosphate receptor-like protein in plasmalemmal caveolae. J Cell Biol 1993, 119:1507-1513.
23. 23 Mastick CC, Brady MJ, Saltiel AR: Insulin stimulates the tyrosine phosphorylation of caveolin. J Cell Biol 1995, 129:1523-1531. Insulin treatment of 3T3-L1 adipocytes causes a specific and rapid phosphorylation of caveolin-1 that parallels phosphorylation of the insulin receptor. Evidence is presented for a role of the p59fyn src family kinase in this pathway. Further studies of downstream components of this signalling pathway should be illuminating.
24. 24. Parpal S, Gustavsson J, Stralfors P: Isolation of phosphooligosaccharide/phosphoinositol glycan from caveolae and cytosol of insulin-stimulated cells. J Cell Biol 1995, 131:125-135.
25. 25. Liu P, Anderson RGW: Compartmentalized production of ceramide at the cell surface. J Biol Chem 1995, 270:27179-27185. Treatment of cells with interleukin-1β initiates a lipid-based signalling pathway in which ceramide is generated via an acid-dependent sphingomyelinase. The substrate sphingomyelin, the generated ceramide, and a small fraction of the cellular acid sphingomyelinase activity are present within a low-density detergent-insoluble fraction which contains caveolar proteins. Whether these components are found within caveolae or whether the enrichment in this fraction reflects their biophysical characteristics remains to be shown. The postulated low pH of the caveolar lumen required for the activity of this sphingomyelinase has also been postulated from previous work [3] but remains to be demonstrated.
26. 26. Brown DA, Rose JK: Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface. Cell 1992, 68:533-544.
27. 27. Fra AM, Williamson E, Simons K, Parton RG: Detergent-insoluble glycolipid microdomains in lymphocytes in the absence of caveolae. J Biol Chem 1994, 269:30745-30748.
28. 28. Gorodinsky A, Harris DA: Glycolipid-anchored proteins in neuroblastoma cells form detergent-resistant complexes without caveolin. J Cell Biol 1995, 129:619-627.
29. 29. Kurzchalia TV, Hartmann E, Dupree P: Guilt by insolubility-does a protein's detergent-insolubility reflect a caveolar location? Trends Cell Biol 1995, 5:187-189. An important article, cautioning against the use of a widely used technique (detergent insolubility and density gradient centrifugation) as a method to establish caveolar localization of proteins and lipids.
30. 30. Schroeder R, London E, Brown D: Interactions between saturated acyl chains confer detergent resistance on lipids and glycosylphosphatidylinositol (GPI)-anchored proteins: GPI-anchored proteins in liposomes and cells show similar behavior. Proc Natl Acad Sci USA 1994, 91:12130-12134.
31. 31. Parton RG, Simons K: Digging into caveolae. Science 1995, 269:1398-1399. Presents a hypothesis regarding the role of DIGs in caveolar formation.
32. 32. Shenoy SA, Dietzen DJ, Kwong J, Link DC, Lublin DM: Cysteine3 of Src family protein tyrosine kinase determines palmitoylation and localization in caveolae. J Cell Biol 1994, 126:353-363.
33. 33. Fra AM, Williamson E, Simons K, Parton RG: De novo formation of caveolae in lymphocytes by expression of VIP21-caveolin. Proc Natl Acad Sci USA 1995, 92:8655-8659. VIP21-caveolin (caveolin-1) expressed in a lymphocyte cell line caused de novo formation of invaginations which displayed the morphology of caveolae. A threshold level of protein on the cell surface was required for caveolar formation. Remarkably, these invaginations had exactly the same morphology as caveolin-1-positive caveolae of fibroblasts and were able to concentrate antibody-clustered GPI-anchored proteins.
34. 34. Sargiacomo M, Scherer PE, Tang Z, Kuebler E, Song KS, Sanders M, Lisanti MP: Oligomeric structure of caveolin: implications for caveolae membrane organization. Proc Natl Acad Sci USA 1995, 92:9407-9411. Fusion proteins containing polypeptides corresponding to regions of the amino terminus of caveolin-1 were shown to oligomerize in vitro. This system was used to define domains of the molecule involved in oligomerization.
35. 35. Fra AM, Masserini M, Palestini P, Sonnino S, Simons K: A photo-reactive derivative of ganglioside GM1 specifically cross-links VIP21-caveolin on the cell surface. FEBS Lett 1995, 375:11-14.
36. 36. Murata M, Kurzchalia T, Peranen J, Schreiner R, Wieland FT, Kurzchalia T, Simons K: VIP21-caveolin is a cholesterol-binding protein. Proc Natl Acad Sci USA 1995, 92:10339-10343. VIP21-caveolin (caveolin-1) is shown to bind cholesterol with high avidity. Cholesterol was required for reconstitution of caveolin-1 within liposomes (see also [16•]). The results show for the first time that caveolin-1 is a cholesterol-binding protein. This could account for some of the effects of cholesterol-binding drugs on caveolar form and function and suggests that caveolin-cholesterol interactions may be involved in caveolae formation.
37. 37. Rothberg K, Ying Y, Kamen BA, Anderson RGW: Cholesterol controls the clustering of the glycophospholipid-anchored membrane receptor for 5-methyltetrahydrofolate. J Cell Biol 1990, 111:2931-2938.
38. 38. Fielding PE, Fielding CJ: Plasma membrane caveolae mediate the efflux of cellular free cholesterol. Biochemistry 1995, 34:14288-14292.
39. 39. Parton RG, Joggerst B, Simons K: Regulated internalization of caveolae. J Cell Biol 1994, 127:1199-1215.
40. 40. Lamaze C, Schmid SL: The emergence of clathrin-independent pinocytic pathways. Curr Opin Cell Biol 1995, 7:573-580. An excellent overview of the current literature on clathrin-independent endocytic pathways, including those which may involve caveolae.
41. 41. Schnitzer JE, Liu J, Oh P: Endothelial caveotae have the molecular transport machinery for vesicle budding, docking, and fusion including VAMP, NSF, SNAP, annexins, and GTPases. J Biol Chem 1995, 270:14399-14404. Describes the isolation of a caveolar fraction enriched in components required for vesicle formation, docking, and fusion, including the N-ethylmaleimide-sensitive fusion factor NSF and its attachment protein, soluble NSF attachment protein (SNAP), the vesicle SNAP receptor (v-SNARE) VAMP-2, and small GTPases. The results suggest that caveolae of endothelial cells have all the machinery they require to act in their postulated role as vesicular carriers.
42. 42. Smart EJ, Ying YS, Anderson RGW: Hormonal regulation of caveolae internalization. J Cell Biol 1995, 131:929-938. Evidence is presented for the role of protein kinase C-α in caveolar invagination. The association of protein kinase C-α with the caveolar membrane and the invagination process are inhibited by treatment of the cells with histamine.
43. 43. Hjelle JT, Christensen EI, Carone FA, Selhub J: Cell fractionation and electron microscope studies of kidney folate-binding protein. Am J Physiol 1991, 260:338-346.
44. 44. Birn H, Selhub J, Christensen EI: Internalization and intracellular transport of folate-binding protein in rat kidney proximal tubule. Am J Physiol 1993, 264:302-310.
45. 45. Rijnboutt S, Jansen G, Strous GJ: Endocytosis of GPI-linked membrane folate receptor-alpha. J Cell Biol 1996, 132:35-47.
46. 46. Ritter TE, Fajardo O, Matsue H, Anderson RG, Lacey SW: Folate receptors targeted to clathrin-coated pits cannot regulate vitamin uptake. Proc Natl Acad Sci USA 1995, 92:3824-3828. Wild-type (GPI-anchored) folate receptors or hybrids (containing the extracellular domain of the folate receptor and the transmembrane and cytoplasmic domains of the LDL receptor) were expressed in cell lines which lacked endogenous receptor. Although both constructs could accumulate folate, the uptake of folate was unregulated in the hybrid-expressing cells. This suggests a vital role of the anchor in coupling uptake to the level of folate in the cytoplasm, possibly by bringing the receptor to the appropriate membrane domain.
47. 47. Ying Y-S, Anderson RGW, Rothberg KG: Each caveola contains multiple glycosyt-phosphatidylinositol anchored membrane proteins. Cold Spring Harb Symp Quant Biol 1992, 57:593-604.
48. 48. Smart EJ, Ying YS, Anderson RG: A detergent-free method for purifying caveolae membrane from tissue culture cells. Proc Natl Acad Sci USA 1995, 92:10104-10108.
49. 49. Stahl A, Mueller BM: The urokinase-type plasminogen activator receptor, a GPI-linked protein, is localized in caveolae. J Cell Biol 1995, 129:335-344.
50. 50. Schnitzer JE, McIntosh DP, Dvorak AM, Liu J, Oh P: Separation of caveolae from associated microdomains of GPI-anchored proteins. Science 1995, 269:1435-1439. A novel subcellular fractionation scheme is used to purify caveolar domains from lung endothelia. A fraction enriched in caveolin and the ganglioside GM1 is depleted of GPI-anchored proteins.
51. 51. Mayor S, Rothberg K, Maxfield F: Sequestration of GPI-anchored proteins in caveolae triggered by crosslinking. Science 1994. 264:1948-1951.
52. 52. Mayor S, Maxfield FR: Insolubility and redistribution of GPI-anchored proteins at the cell surface after detergent treatment. Mol Biol Cell 1995, 6:929-944.
53. 53. Conrad PA, Smart EJ, Ying YS, Anderson RGW, Bloom GS: Caveolin cycles between plasma membrane caveolae and the Golgi complex by microtubule-dependent and microtubule-independent steps. J Cell Biol 1996, 131:1421-1433. Microtubule depolymerization causes caveolin to redistribute from the cell surface to the perinuclear area of the cell where it colocalizes partially with markers of the ER-Golgi intermediate compartment. Evidence is presented for a rapid caveolin-cycting pathway via the ER and Golgi complex: this evidence is in support of previous studies with cholesterol oxidase [54] but the mechanisms involved, and the exact pathway followed by caveolin, remain a mystery.
54. 54. Smart EJ, Ying YS, Conrad PA, Anderson RGW: Caveolin moves from caveolae to the Golgi apparatus in response to cholesterol oxidation. J Cell Biol 1994, 127:1185-1197.
55. 55. Kurzchalia TV, Parton RG: And still they are moving...Dynamic properties of caveolae. FEBS Lett 1996, in press.
56. 56. Parton RG: Ultrastructural localization of gangliosides; GM1 is concentrated in caveolae. J Histochem Cytochem 1994, 42:155-166.
57. 57 Novikoff AB, Novikoff PM, Rosen OM, Rubin CS: Organelle relationships in cultured 3T3-L1 preadipocytes. J Cell Biol 1980, 87:180-196.
58. 58. Sargiacomo M, Sudol M, Tang Z, Lisanti MP: Signal transducing molecules and GPI-linked proteins form a caveolin-rich insoluble complex in MDCK cells. J Cell Biol 1993, 122:789-807
59. 59. Glenney JR: Tyrosine phosphorylation of a 22-kDa protein is correlated with phosphorylation by Rous sarcoma virus. J Biol Chem 1989, 264:20163-20166.
60. 60. Li S, Seitz R, Lisanti MP: Phosphorylation of caveolin by Src tyrosine kinases. The alpha-isoform of caveolin is selectively phosphorylated by v-Src in vivo. J Biol Chem 1996, 271:3863-3868.